Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT03836053 · TERMINATED
Trial details
- NCT number
- NCT03836053
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-04
- Primary completion
- 2022-04-21
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.